Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy and unborn babies, warn Flinders University researchers.
A new study has revealed that most Australian women of reproductive age prescribed GLP-1 receptor agonists — medications increasingly used for weight loss such as Ozempic — are not using effective contraception, despite known risks during pregnancy.
Published in the Medical Journal of Australia, the research…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply